Suppr超能文献

纳米医学对眼部药物输送的治疗意义。

Therapeutic implications of nanomedicine for ocular drug delivery.

机构信息

Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA; Center for Pharmaceutical Engineering and Sciences, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA.

Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA; Center for Pharmaceutical Engineering and Sciences, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA; Department of Physics, College of Humanities & Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA.

出版信息

Drug Discov Today. 2019 Aug;24(8):1524-1538. doi: 10.1016/j.drudis.2019.05.006. Epub 2019 May 15.

Abstract

Delivering therapeutics to the eye is challenging on multiple levels: rapid clearance of eyedrops from the ocular surface requires frequent instillation, which is difficult for patients; transport of drugs across the blood-retinal barrier when drugs are administered systemically, and the cornea when drugs are administered topically, is difficult to achieve; limited drug penetration to the back of the eye owing to the cornea, conjunctiva, sclera and vitreous barriers. Nanomedicine offers many advantages over conventional ophthalmic medications for effective ocular drug delivery because nanomedicine can increase the therapeutic index by overcoming ocular barriers, improving drug-release profiles and reducing potential drug toxicity. In this review, we highlight the therapeutic implications of nanomedicine for ocular drug delivery.

摘要

将治疗药物递送到眼部在多个层面上具有挑战性

眼药水从眼部表面迅速清除需要频繁滴注,这对患者来说很困难;当药物全身给药时,药物穿过血视网膜屏障,以及当药物局部给药时,药物穿过角膜,这很难实现;由于角膜、结膜、巩膜和玻璃体的屏障作用,药物有限地渗透到眼睛后部。与传统的眼科药物相比,纳米医学在有效的眼部药物递送方面具有许多优势,因为纳米医学可以通过克服眼部屏障、改善药物释放特性和降低潜在药物毒性来提高治疗指数。在这篇综述中,我们强调了纳米医学在眼部药物递送中的治疗意义。

相似文献

1
Therapeutic implications of nanomedicine for ocular drug delivery.纳米医学对眼部药物输送的治疗意义。
Drug Discov Today. 2019 Aug;24(8):1524-1538. doi: 10.1016/j.drudis.2019.05.006. Epub 2019 May 15.
3
Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.眼部疾病的基础、挑战和基于纳米医学的解决方案。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Jul;11(4):e1548. doi: 10.1002/wnan.1548. Epub 2018 Dec 3.
5
Toxicity of nanomaterials to the eye.纳米材料对眼睛的毒性。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jul-Aug;2(4):317-33. doi: 10.1002/wnan.65.
6
Delivery of therapeutics for deep-seated ocular conditions - status quo.深部眼疾治疗药物的递呈 - 现状。
J Pharm Pharmacol. 2018 Aug;70(8):994-1001. doi: 10.1111/jphp.12924. Epub 2018 Apr 19.
8
Enhancement of ocular drug penetration.眼部药物渗透性的增强。
Crit Rev Ther Drug Carrier Syst. 1999;16(1):85-146.

引用本文的文献

3
Nano-based drug delivery systems for the treatment of non-infectious uveitis.用于治疗非感染性葡萄膜炎的纳米药物递送系统。
Adv Ophthalmol Pract Res. 2024 Nov 12;5(2):124-134. doi: 10.1016/j.aopr.2024.11.003. eCollection 2025 May-Jun.
7
Review: Neuroprotective Nanocarriers in Glaucoma.综述:青光眼的神经保护纳米载体
Pharmaceuticals (Basel). 2024 Sep 10;17(9):1190. doi: 10.3390/ph17091190.

本文引用的文献

1
Depot formulations to sustain periocular drug delivery to the posterior eye segment.用于维持眼周药物向眼后段传递的储库制剂。
Drug Discov Today. 2019 Aug;24(8):1458-1469. doi: 10.1016/j.drudis.2019.03.023. Epub 2019 Mar 28.
7
Biodegradable dendrimers for drug delivery.可生物降解树枝状聚合物用于药物传递。
Mater Sci Eng C Mater Biol Appl. 2018 Sep 1;90:713-727. doi: 10.1016/j.msec.2018.03.002. Epub 2018 Mar 10.
10
The suprachoroidal space as a route of administration to the posterior segment of the eye.脉络膜上腔作为眼后段给药途径。
Adv Drug Deliv Rev. 2018 Feb 15;126:58-66. doi: 10.1016/j.addr.2018.03.001. Epub 2018 Mar 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验